Foracort Synchrobreathe Inhaler 200 mcg (Budesonide/Formoterol) in United states of America , United Kingdom ,France , Australia

Active Ingredient: Budesonide/Formoterol
Indication: Asthma, Chronic obstructive pulmonary disorder (COPD)
Manufacturer: Cipla Limited
Packaging: 120 MDI in 1 Inhaler
Strength: 200mcg

Foracort Synchrobreathe Inhaler 200 mcg (Budesonide / Formoterol)

Foracort Synchrobreathe Inhaler 200 mcg (Budesonide / Formoterol) is a combination inhalation medication used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). It contains Budesonide, a corticosteroid that helps reduce inflammation and swelling in the airways, and Formoterol, a long-acting bronchodilator that relaxes airway muscles and improves airflow to the lungs.

This dual-action therapy helps control airway inflammation and keep airways open, making breathing easier and preventing symptoms such as wheezing, coughing, chest tightness, and shortness of breath. The Synchrobreathe inhaler device ensures efficient delivery of medication directly into the lungs for better respiratory control.

TabExports supplies Foracort Synchrobreathe Inhaler 200 mcg (Budesonide / Formoterol) to global pharmaceutical markets with reliable export services and consistent product quality.

The product ID is missing or the ID provided does not correspond to a variable product.

Foracort Synchrobreathe Inhaler 200 mcg (Budesonide / Formoterol)

Foracort Synchrobreathe Inhaler 200 mcg (Budesonide / Formoterol) is a combination inhalation medication used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). It contains Budesonide, a corticosteroid that helps reduce inflammation and swelling in the airways, and Formoterol, a long-acting bronchodilator that relaxes airway muscles and improves airflow to the lungs.

This dual-action therapy helps control airway inflammation and keep airways open, making breathing easier and preventing symptoms such as wheezing, coughing, chest tightness, and shortness of breath. The Synchrobreathe inhaler device ensures efficient delivery of medication directly into the lungs for better respiratory control.

TabExports supplies Foracort Synchrobreathe Inhaler 200 mcg (Budesonide / Formoterol) to global pharmaceutical markets with reliable export services and consistent product quality.

Key Benefits

  • Helps control asthma and COPD symptoms

  • Reduces airway inflammation

  • Improves airflow to the lungs

  • Helps prevent wheezing and breathing difficulties

  • Provides long-lasting respiratory support

Uses

  • Asthma management

  • Chronic obstructive pulmonary disease (COPD)

  • Prevention of bronchospasm

  • Long-term respiratory therapy

Active Ingredients

  • Budesonide

  • Formoterol

Global Supply by TabExports

TabExports exports Foracort Synchrobreathe Inhaler 200 mcg (Budesonide / Formoterol) to international markets including the United States of America, the United Kingdom, France, Australia, and Thailand. We ensure high-quality pharmaceutical products with secure packaging and reliable global delivery.

Storage Instructions

Store in a cool and dry place away from direct sunlight. Keep the inhaler in its original packaging and out of reach of children.

Disclaimer

Use this medication only as prescribed by a healthcare professional. Do not exceed the recommended dosage without medical advice.

Reviews

There are no reviews yet.

Be the first to review “Foracort Synchrobreathe Inhaler 200 mcg (Budesonide/Formoterol) in United states of America , United Kingdom ,France , Australia”

Your email address will not be published. Required fields are marked *

Scroll to Top